GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Pancreas Transcription Factors and Disease Model Systems

$297,463
Stephen F Konieczny · Purdue University · R01 · FY2013 · DK

Somatostatin Analogs as Countermeasures against Intestinal Radiation Toxicity

$297,400
Martin Hauer-Jensen · Duke University · U19 · FY2012 · AI

Molecular targeting of the survivin pathway in cancer

$297,399
Dario C. Altieri · Univ Of Massachusetts Med Sch Worcester · R01 · FY2006 · CA

Role of RNase L in the Biology of Prostate Cancer

$297,398
Robert H. Silverman · Cleveland Clinic Lerner Com-Cwru · R01 · FY2007 · CA

Development of Oligonucleotide-based CTLA-4 Inhibitors

$297,398
Eli Gilboa · University Of Miami School Of Medicine · R01 · FY2008 · CA

Role of RNase L in the Biology of Prostate Cancer

$297,398
Robert H. Silverman · Cleveland Clinic Lerner Com-Cwru · R01 · FY2008 · CA

Development Control in C. elegans

$297,357
Min Han · University Of Colorado · R01 · FY2020 · GM

Wnt/beta-catenin signaling in exocrine pancreas developoment and regeneration

$297,342
Lewis C Murtaugh · University Of Utah · R01 · FY2010 · DK

Role of NFkappaB Activity of BITC against Pancreatic Ca.

$297,272
Sanjay K Srivastava · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · CA

Development of Oligonucleotide-based CTLA-4 Inhibitors

$297,236
Eli Gilboa · University Of Miami School Of Medicine · R01 · FY2007 · CA

Fanconi Defects in Pancreatic Cancer Oncogenesis

$297,083
Scott E Kern · Johns Hopkins University · R01 · FY2011 · CA

Novel Human Cancer Cell Isolation System

$297,082
James R. Eshleman · Johns Hopkins University · R01 · FY2011 · CA

Phospho-valproic acid for pancreatic cancer prevention

$297,042
Basil Rigas · State University New York Stony Brook · R01 · FY2013 · CA

Fluorescent nanoparticles to improve resections of microscopic pancreatic tumors

$296,990
Aaron Henry Colby · Ionic Pharmaceuticals · R43 · FY2018 · CA

High Throughput Screening for SCAP Inhibitors as Pancreas Cancer Therapeutics

$296,913
Peter John Espenshade · Johns Hopkins University · R01 · FY2023 · CA

SURGICAL STUDIES OF PANCREATIC STEM CELLS

$296,808
Johns Hopkins University · R01 · FY2002 · DK

In situ detection of apoptosis in tumor endothelial cells

$296,752
University Of Texas Md Anderson Can Ctr · U54 · FY2002 · CA

CORE--PATHOLOGY

$296,752
Thomas Jefferson University · P01 · FY2002 · CA

CORE--PATHOLOGY

$296,752
Thomas Jefferson University · P01 · FY2002 · CA

CORE--PATHOLOGY

$296,752
Thomas Jefferson University · P01 · FY2001 · CA

Core--Clinical trials

$296,752
University Of Texas Md Anderson Can Ctr · U54 · FY2002 · CA

T Cell Immunity to Epithelial Tumor Mucins

$296,687
University Of Pittsburgh At Pittsburgh · R01 · FY2002 · CA

Basic Science Research in Digestive Diseases

$296,654
Mark Donowitz · Johns Hopkins University · T32 · FY2011 · DK

Engineering enzymatic activity of a cancer therapeutic tospecifically target extracellular matrix in the tumor microenvironment

$296,648
Glenn E Croston · Phenzyme, Inc. · R43 · FY2017 · CA

A PATIENT-CENTRIC APPROACH TO IMPROVING GUIDELINE-CONCORDANT CARE IN PANCREATIC CANCER: USING MODIFIABLE BARRIERS TO IDENTIFY PATIENTS AT RISK FOR DISPARITIES

$296,618
University Of Alabama At Birmingham · · FY2024 · Defense Health Agency